Coegin Pharma Investor Relations Material
Latest events
Status Update
Coegin Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Coegin Pharma
Access all reports
Coegin Pharma AB is a biotechnology company specializing in the development of small molecule therapies targeting inflammatory and cancer-related diseases. The company leverages its expertise in molecular biology and drug development to create innovative treatments aimed at addressing unmet medical needs in its focus areas. Coegin Pharma collaborates with research institutions and industry partners to advance its therapeutic pipeline. The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
COEGIN
Country
🇸🇪 Sweden